American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: https://www.sciepub.com/journal/ajmcr Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2016, 4(7), 251-254
DOI: 10.12691/ajmcr-4-7-10
Open AccessCase Report

Nocardia arthritidis Infection in an Immunocompetent Human in the United States

Osamuyimen Igbinosa1, , Owen Igbinosa2, Krishna Dass1 and Glenn Wortmann1

1Section of Infectious Diseases, MedStar Washington Hospital Center, Washington DC USA

2Department of medicine, Obafemi Awolowo University Teachings Hospitals Complex, Ile-Ife, Nigeria

Pub. Date: August 12, 2016

Cite this paper:
Osamuyimen Igbinosa, Owen Igbinosa, Krishna Dass and Glenn Wortmann. Nocardia arthritidis Infection in an Immunocompetent Human in the United States. American Journal of Medical Case Reports. 2016; 4(7):251-254. doi: 10.12691/ajmcr-4-7-10

Abstract

Patients with T-cell defects are at the highest risk for nocardiosis, a potentially life-threatening infection caused by several species of the genus, Nocardia. We report a case of disseminated Nocardia arthritidis in a patient who had no recognizable risk factors for immunodeficiency. A 43-year-old woman was noted to have a left upper lobe cavitary lesion on an outpatient computerized tomography (CT) scan that was performed for evaluation of pelvic congestion syndrome. She subsequently had an image-guided biopsy of the lesion, but the results were still pending when she presented at the emergency department with a transient episode of aphasia. A CT scan of the patient’s head revealed hypodensities in the right frontoparietal and left frontal lobes. A modified acid-fast stain on the lung biopsy specimen demonstrated variable, branching, filamentous bacteria with morphology consistent with Nocardia species. Matrix-Assisted Laser Desorption / Ionization – Time-of-Flight (MALDI-TOF) Mass Spectrometry at a reference laboratory later identified the bacteria as Nocardia arthritidis. This case highlights that disseminated nocardiosis can occur in an apparently healthy population. A more detailed immunologic evaluation that include screening for chronic granulomatous disease, anticytokine autoantibody deficiency and interleukin-12-gamma interferon pathway deficiency may further assist in the diagnosis of patients’ underlying diseases.

Keywords:
Norcadiosis Norcadia arthritidis Immunocompromised

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Beaman, B. L., Burnside, J., Edwards, B. & Causey, W. (1976). Nocardial infections in the United States, 1972-1974, J Infect Dis 134: (3) 286-289.
 
[2]  Wilson, J. W. (2012). Nocardiosis: updates and clinical overview. Mayo Clin Proc.87: 403-407.
 
[3]  Hwang, J. H., Koh, W. J., Suh, G. Y., et al. (2004). Pulmonary nocardiosis with multiple cavitary nodules in a HIV-negative immunocompromised patient Intern Med 43(9): 852-854.
 
[4]  Conville, P. S., Brown, J. M., Steigerwalt, A. G., et al. (2008). Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov., human pathogens and members of the “Nocardia transvalensis Complex”. J Clin Microbiol 2008; 46: 1178.
 
[5]  Kageyama, A., Torikoe, K., Iwamoto, M., et al. (2004). Nocardia arthritidis sp. nov., a New Pathogen Isolated from a Patient with Rheumatoid Arthritis in Japan J Clin Microbiol. 2004 Jun; 42(6): 2366-2371.
 
[6]  Aragaki-Nakahodo, A., Benzaquen, S. & Kirschner, M. (2014). Coinfection by Nocardia beijingensis and Nocardia arthritidis in an immunocompromised patient diagnosed by endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) Respir Med Case Rep 12: 22e23.
 
[7]  Brown-Elliott, B. A., Brown, J. M., Conville, P. S., Wallace, R. J. (2006). Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 19: 259-282.
 
[8]  Uhde, K. B., Pathak, S., McCullum, I. Jr., et al. (2010). Antimicrobial-resistant nocardia isolates, United States, 1995-2004. Clin Infect Dis 51: 1445-1448.
 
[9]  Beaman, B.L. & Beaman, L. (1994) Nocardia species: host-parasite relationships. Clin Microbiol Rev. 7: 213-264.
 
[10]  Yu, X., Han, F., Wu, J., et al. (2011). Nocardia infection in kidney transplant recipients: Case report and analysis of 66 published cases. Transpl Infect Dis. 13: 385-391.
 
[11]  Kundranda, M. N., Spiro, T. P., Muslimani, A., et al. (2007). Cerebral nocardiosis in a patient with NHL treated with rituximab. Am J Hematol. 82: 1033-1034.
 
[12]  Punatar, A. D., Kusne, S., Blair, J. E., Seville, M. T. & Vikram, H. R. (2012). Opportunistic infections in patients with pulmonary alveolar proteinosis. J Infect. 65(2): 173-9.
 
[13]  Bergstrom, R., Edebo, L., Fors, B. & Tegner, K. B. (1966). Systemic Nocardia infection. Scand J Respir Dis. 47: 75-84.
 
[14]  Debieuvre, D., Dalphin, J. C., Jacoulet, P., et al. (1993). Disseminated infection due to an unusual strain of Nocardia farcinica (Fre). Rev Mal Respir. 10: 356-358.
 
[15]  Torres, O. H., Domingo, P., Pericas, R. et al. (2000). Infection caused by Nocardia farcinica: Case report and review. Eur J Clin Microbiol Infect Dis. 19: 205-212.
 
[16]  Rosen, L. B., Rocha, P. N., Figueiredo, C., et al. (2015). Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/ extrapulmonary nocardiosis. Clin Infect Dis. 1; 60(7): 1017-25.
 
[17]  Lederman, E. R. & Crum, N. F. (2004). A case series and focused review of nocardiosis: clinical and microbiologic aspects. Medicine (Baltimore) 83: 300-313.
 
[18]  Martinez, R., Reyes, S. & Menendez, R. (2008). Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis. Curr. Opin. Pulm. Med. 14: 219-227.
 
[19]  Wayne, L. G., Brenner, D. J., Colwell, R. R., et al. (1987). International Committee on Systematic Bacteriology. Report of the Ad Hoc Committee on reconciliation of approaches to bacterial systematics. Int J Syst Bacteriol. 37: 463-464.
 
[20]  Kageyama, A., Poonwan, N., Yazawa, K., Mikami, Y. & Nishimura, K. (2004). Nocardia beijingensis is a pathogenic bacterium to humans: the first infectious cases in Thailand and Japan. Mycopathology 157: 155-161.
 
[21]  Crozier, J. A., Andhavarapu, S., Brumble, L. M. & Sher, T., (2014). First Report of Nocardia beijingensis Infection in an Immunocompetent Host in the United States. J Clin Microbiol. 52(7): 2730-2732.